Диссертация (1145849), страница 23
Текст из файла (страница 23)
– V. 6. – №. 6. – P. 745-757.95. Fiorina P., Jurewicz M., Augello A., Vergani A., Dada S., La Rosa S., Selig M.,Godwin J., Law K., Placidi C., Smith R.N., Capella C., Rodig S., Adra .CN.,Atkinson M., Sayegh M.H., Abdi R. Immunomodulatory function of bonemarrow-derived mesenchymal stem cells in experimental autoimmune type 1diabetes //The Journal of Immunology. – 2009. – V. 183.
– №. 2. – P. 993-1004.96. Fong C.Y., Subramanian A., Biswas A., Gauthaman K., Srikanth P., HandeM.P., Bongso A. Derivation efficiency, cell proliferation, freeze–thaw survival,stem-cell properties and differentiation of human Wharton’s jelly stem cells//Reproductive biomedicine online.
– 2010. – V. 21. – №. 3. – P. 391-401.97. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the developmentand function of CD4+ CD25+ regulatory T cells //Nature immunology. – 2003.– V. 4. – №. 4. – P. 330-336.98. Forbes G.M., Sturm M.J., Leong R.W., Sparrow M.P., SegarajasingamD., Cummins A.G., Phillips M., Herrmann R.P.. A phase 2 study of allogeneicmesenchymal stromal cells for luminal Crohn's disease refractory to biologictherapy //Clinical Gastroenterology and Hepatology.
– 2014. – V. 12. – №. 1. –P. 64-71.13899. Franquesa M., Hoogduijn M.J., Bestard O., Grinyó J.M. Immunomodulatoryeffect of mesenchymal stem cells on B cells //Frontiers in immunology. – 2012.– V. 3.100. Fraser J.K., Wulur I., Alfonso Z., Hedrick M.H. Fat tissue: an underappreciatedsource of stem cells for biotechnology //Trends in biotechnology. – 2006. – V.24. – №. 4. – P.
150-154.101. Frazier T.P., McLachlan J.B., Gimble J.M., Tucker H.A., Rowan B.G. HumanAdipose-Derived Stromal/Stem Cells Induce Functional CD4+ CD25+ FoxP3+CD127− Regulatory T Cells Under Low Oxygen Culture Conditions //Stemcells and development. – 2014. – V. 23. – №. 9. – P. 968-977.102.
Fukuchi Y., Nakajima H., Sugiyama D., Hirose I., Kitamura T., Tsuji K. Humanplacenta-derived cells have mesenchymal stem/progenitor cell potential //Stemcells. – 2004. – V. 22. – №. 5. – P. 649-658.103. Funderburg N., Lederman M.M., Feng Z., Drage M.G., Jadlowsky J., HardingC.V., Weinberg A., Sieg S.F. Human β-defensin-3 activates professionalantigen-presenting cells via Toll-like receptors 1 and 2 //Proceedings of theNational Academy of Sciences. – 2007.
– V. 104. – №. 47. – P. 18631-18635.104. Fujita N., Kato Y., Naito M., Tsuruo T. A novel anti-Thy-1 (CD90) monoclonalantibody induces apoptosis in mouse malignant T-lymphoma cells in spite ofinducing bcl-2 expression // International journal of cancer. – 1996. – V. 66. –№. 4. – P. 544-550.105. Galipeau J. The mesenchymal stromal cells dilemma—does a negative phase IIItrial of random donor mesenchymal stromal cells in steroid-resistant graftversus-host disease represent a death knell or a bump in the road? //Cytotherapy.– 2013. – V. 15. – №. 1. – P.
2-8.106. Gauzzi M.C., Del Cornò M., Gessani S. Dissecting TLR3 signalling in dendriticcells //Immunobiology. – 2010. – V. 215. – №. 9. – P. 713-723..107. Gemou-Engesaeth V., Masao Toda M.K., Hamid Q., Halvorsen S., GroegaardJ.B., Corrigan C.J. Expression of activation markers and cytokine mRNA byperipheral blood CD4 and CD8 T cells in atopic and nonatopic childhoodasthma: effect of inhaled glucocorticoid therapy //Pediatrics.
– 2002. – V. 109. –№. 2. – P. e24-e24.108. Ghannam S., Pene J., Torcy-Moquet G., Jorgensen C., Yssel H. Mesenchymalstem cells inhibit human Th17 cell differentiation and function and induce a Tregulatory cell phenotype //The Journal of Immunology. – 2010. – V. 185.
– №.1. – P. 302-312.139109. Ghosh S., Karin M. Missing pieces in the NF-κB puzzle //Cell. – 2002. – V.109. – №. 2. – P. S81-S96.110. Gimble J.M., Katz A.J., Bunnell B.A. Adipose-derived stem cells forregenerative medicine //Circulation research. – 2007. – V. 100. – №.
9. – P.1249-1260.111. Giuliani M., Bennaceur-Griscelli A., Nanbakhsh A., Oudrhiri N., Chouaib S.,Azzarone B., Durrbach A., Lataillade J.J. TLR ligands stimulation protects MSCfrom NK killing //Stem Cells. – 2014. – V. 32. – №. 1. – P. 290-300.112. Glenn J.D., Whartenby K.A. Mesenchymal stem cells: Emerging mechanisms ofimmunomodulation and therapy //World journal of stem cells.
– 2014. – V. 6. –№. 5. – P. 526.113. Glennie S., Soeiro I., Dyson P.J., Lam E.W.F., Dazzi F. Bone marrowmesenchymal stem cells induce division arrest anergy of activated T cells//Blood. – 2005. – V. 105. – №. 7. – P. 2821-2827.114. Gnecchi M., Zhang Z., Ni A., Dzau V.J. Paracrine mechanisms in adult stemcell signaling and therapy //Circulation research. – 2008. – V. 103. – №. 11.
– P.1204-1219.115. Goodwin M. Sueblinvong V., Eisenhauer P., Ziats N.P., LeClair L., PoynterM.E., Steele C., Rincon M., Weiss D.J. Bone marrow-derived mesenchymalstromal cells inhibit Th2-mediated allergic airways inflammation in mice //StemCells. – 2011.
– V. 29. – №. 7. – P. 1137-1148.116. Gonzalez-Rey E., Gonzalez M.A., Varela N., O’Valle F., Hernandez-Cortes P.,Rico L., Buscher D., Delgado M. Human adipose-derived mesenchymal stemcells reduce inflammatory and T cell responses and induce regulatory T cells invitro in rheumatoid arthritis //Annals of the Rheumatic Diseases. – 2010. – V.69.
– №. 01. – P. 241-248.117. Gonzalez M.A., Gonzalez-Rey E., Rico L., Buscher D., Delgado M. Adiposederived mesenchymal stem cells alleviate experimental colitis by inhibitinginflammatory and autoimmune responses //Gastroenterology. – 2009. – V. 136.– №. 3. – P. 978-989.118. Gorelik L., Constant S., Flavell R.A. Mechanism of transforming growth factorβ–induced inhibition of T helper type 1 differentiation //The Journal ofexperimental medicine. – 2002.
– V. 195. – №. 11. – P. 1499-1505.119. Grayson W.L., Zhao F., Bunnell B., Ma T. Hypoxia enhances proliferation andtissue formation of human mesenchymal stem cells //Biochemical andbiophysical research communications. – 2007. – V. 358. – №. 3. – P. 948-953.140120. Greten F.R.
Arkan M.C., Bollrath J., Hsu L.C., Goode J., Miething C., GöktunaS.I., Neuenhahn M., Fierer J., Paxian S., Van Rooijen N., Xu Y., O'Cain T.,Jaffee B.B., Busch D.H., Duyster J., Schmid R.M., Eckmann L., Karin M. NFκB is a negative regulator of IL-1β secretion as revealed by genetic andpharmacological inhibition of IKKβ //Cell. – 2007. – V. 130. – №.
5. – P. 918931.121. Groh M.E., Maitra B., Szekely E., Koç O.N. Human mesenchymal stem cellsrequire monocyte-mediated activation to suppress alloreactive T cells//Experimental hematology. – 2005. – V. 33. – №. 8. – P. 928-934.122. Gros C., Giros B., Schwartz J.C. Identification of aminopeptidase M as anenkephalin-inactivating enzyme in rat cerebral membranes //Biochemistry. –1985. – V. 24. – №. 9. – P. 2179-2185.123. Grote K., Petri M., Liu C., Jehn P., Spalthoff S., Kokemüller H., Luchtefeld M.,Tschernig T., Krettek C., Haasper C., Jagodzinski M. Toll-like receptor 2/6dependent stimulation of mesenchymal stem cells promotes angiogenesis byparacrine factors //Europ Cells Mater.
– 2013. – V. 26. – P. 66-79.124. Guy K., Middleton P.G., Steel C.M. Variant sublines of the human B-lymphomacells Namalwa are at different stages of differentiation //Immunology. – 1987. –V. 61. – P. 383-386.125. Hagood J.S., Mangalwadi A., Guo B., MacEwen M.W., Salazar L., Fuller G.M.Concordant and Discordant Interleukin-1–Mediated Signaling in LungFibroblast Thy-1 Subpopulations //American journal of respiratory cell andmolecular biology. – 2002. – V. 26. – №. 6.
– P. 702-708.126. Hamann J., Fiebig H., Strauss M. Expression cloning of the early activationantigen CD69, a type II integral membrane protein with a C-type lectin domain//The Journal of Immunology. – 1993. – V. 150. – №. 11. – P. 4920-4927.127. Han Y., Guo Q., Zhang M., Chen Z., Cao X. CD69+ CD4+ CD25− T cells, anew subset of regulatory T cells, suppress T cell proliferation throughmembrane-bound TGFβ1 //The Journal of Immunology. – 2009. – V. 182. – №.1. – P. 111-120.128.
Halfon S., Abramov N., Grinblat B., Ginis I. Markers distinguishingmesenchymal stem cells from fibroblasts are downregulated with passaging//Stem cells and development. – 2010. – V. 20. – №. 1. – P. 53-66.129. Hardy R.R, Hayakawa K. B cell development pathways //Annu. Rev. Immunol.– 2001. – V.19. – P.595-621.130. Hashikawa T., Takedachi M., Terakura M., Saho T., Yamada S., ThompsonL.F., Shimabukuro Y., Murakami S. Involvement of CD73 (ecto-5′141nucleotidase) in adenosine generation by human gingival fibroblasts //Journal ofdental research. – 2003. – V. 82. – №. 11.
– P. 888-892.131. Haque N., Rahman M.T., Abu Kasim N.H., Alabsi A.M. Hypoxic cultureconditions as a solution for mesenchymal stem cell based regenerative therapy//The Scientific World Journal. – 2013. – V. 2013132. Hayden M.S., Ghosh S. Shared principles in NF-κB signaling //Cell. – 2008.
–V. 132. – №. 3. – P. 344-362.133. Han Y., Guo Q., Zhang M., Chen Z., Cao X. CD69+ CD4+ CD25− T cells, anew subset of regulatory T cells, suppress T cell proliferation throughmembrane-bound TGF-β1 //The Journal of Immunology. – 2009. – V. 182. – №.1.
– P. 111-120.134. He J., Liu Y., Zhu T., Zhu J., Dimeco F., Vescovi A.L., Heth J.A., MuraszkoK.M., Fan X., Lubman D.M. CD90 is identified as a candidate marker forcancer stem cells in primary high-grade gliomas using tissue microarrays//Molecular & Cellular Proteomics. – 2012. – V. 11.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
